TITLE

Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice

AUTHOR(S)
Yokoi, H; Mukoyama, M.; Mori, K.; Kasahara, M.; Suganami, T.; Sawai, K.; Yoshioka, T.; Saito, Y.; Ogawa, Y.; Kuwabara, T.; Sugawara, A.; Nakao, K.
PUB. DATE
February 2008
SOURCE
Kidney International;Feb2008, Vol. 73 Issue 4, p446
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Connective tissue growth factor (CTGF) is a potent inducer of extracellular matrix accumulation. In diabetic nephropathy, CTGF expression is markedly upregulated both in podocytes and mesangial cells, and this may play an important role in its pathogenesis. We established podocyte-specific CTGF-transgenic mice, which were indistinguishable at baseline from their wild-type littermates. Twelve weeks after streptozotocin-induced diabetes, these transgenic mice showed a more severe proteinuria, mesangial expansion, and a decrease in matrix metalloproteinase-2 activity compared to diabetic wild-type mice. Furthermore, diabetic transgenic mice exhibited less podocin expression and a decreased number of diffusely vacuolated podocytes compared to diabetic wild-type mice. Importantly, induction of diabetes in CTGF-transgenic mice resulted in a further elevation of endogenous CTGF mRNA expression and protein in the glomerular mesangium. Our findings suggest that overexpression of CTGF in podocytes is sufficient to exacerbate proteinuria and mesangial expansion through a functional impairment and loss of podocytes.Kidney International (2008) 73, 446–455; doi:10.1038/sj.ki.5002722; published online 12 December 2007
ACCESSION #
28724603

 

Related Articles

  • Unraveling the role of connective tissue growth factor in diabetic nephropathy. Schmidt-Ott, K. M. // Kidney International;Feb2008, Vol. 73 Issue 4, p375 

    Marked upregulation of the secreted extracellular matrix-associated protein connective tissue growth factor (CTGF) in the glomerulus coincides with the onset of diabetic nephropathy. Recent studies, including the one by Yokoi et al., shed light on the role of CTGF in glomerular injury.Kidney...

  • A race for RAGE ligands. Schleicher, Erwin D. // Kidney International;Aug2010, Vol. 78 Issue 3, p234 

    In experimental animals a causal involvement of the multiligand receptor for advanced glycation end products (RAGE) in the development of diabetic vascular complications has been demonstrated. However, the nature of RAGE ligands present in patients with diabetic nephropathy has not yet been...

  • Defensive medicine in diabetic nephropathy. Friedman, Eli A. // Kidney International Supplement;Dec1985, Issue 17, pS120 

    Discusses the rationale for defensive medicine in diabetic nephropathy. Causes of diabetic nephropathy; Factors in the initiation and progression of diabetic vascular disease; Prevention of diabetic nephropathy.

  • The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy. Ji, Hongfei; Wu, Lina; Ma, Xiaokun; Ma, Xiaojun; Qin, Guijun // Molecular Biology Reports;Apr2014, Vol. 41 Issue 4, p2151 

    Adiponectin is an adipocyte derived protein that plays pivotal roles in anti-oxidation, anti-inflammatory and insulin-sensitizing properties by activating two receptors, AdipoR1 and AdipoR2. Recent studies have shown that the down-regulation of AdipoR1 is a known cause of diabetic nephropathy...

  • Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy. Minamino, Tohru; Komuro, Issei // Vascular Disease Prevention;Jul2007, Vol. 4 Issue 3, p194 

    Excessive calorie intake induces metabolic dysfunction and obesity, leading to the development of type 2 diabetes. Diabetic macroangiopathy is one of the most important complications of type 2 diabetes and it increases the risk of vascular events. Recent clinical studies suggest that impaired...

  • Macrophage Scavenger Receptor-A-Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation. Usui, Hitomi Kataoka; Shikata, Kenichi; Sasaki, Motofumi; Okada, Shinichi; Matsuda, Mitsuhiro; Shikata, Yasushi; Ogawa, Daisuke; Kido, Yuichi; Nagase, Ryo; Yozai, Kosuke; Ohga, Sakiko; Tone, Atsuhito; Wada, Jun; Takeya, Masahiro; Horiuchi, Seikoh; Kodama, Tatsuhiko; Makino, Hirofumi // Diabetes;Feb2007, Vol. 56 Issue 2, p363 

    Microinflammation is a common major mechanism in the pathogenesis of diabetic vascular complications, including diabetic nephropathy. Macrophage scavenger receptor-A (SR-A) is a multifunctional receptor expressed on macrophages. This study aimed to determine the role of SR-A in diabetic...

  • IS HYPERFILTRATION ASSOCIATED WITH THE FUTURE RISK OF DEVELOPING DIABETIC NEPHROPATHY? A META-ANALYSIS. Magee, Glynis M.; Bilous, Rudy; Cardwell, Chris R.; Hunter, Steven J.; Kee, Frank; Fogarty, Damian G. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p63 

    Aims: Glomerular hyperfiltration is well established as a phenomenon occurring early in type 1 and type 2 diabetes, however, there is no consistent answer regarding whether hyperfiltration predicts the later development of nephropathy. We performed a systematic review and meta-analysis of...

  • The role of protein kinase C activation in diabetic nephropathy. Noh, H.; King, G. L. // Kidney International Supplement;Aug2007, Issue 106, p49 

    Diabetic nephropathy is the leading cause of end-stage renal disease worldwide and an independent risk factor for all-cause and cardiovascular mortalities in diabetic patients. New insights into the molecular mechanisms that underlie the development and progression of microvascular complications...

  • MaÅ‚a czÄ™stość wystÄ™powania cukrzycowej choroby nerek w cukrzycy typu 1. Walczak, Konrad; Szadkowska, Agnieszka; Majda, Agnieszka; Madej, Anna; Moczulski, Dariusz // Experimental & Clinical Diabetology / Diabetologia Doswiadczalna;2010, Vol. 10 Issue 2, p97 

    Background. Diabetic kidney disease is one of the microangiopatic complication which develops in type 1 diabetes patients. The aim of the study was to assess the prevalence of diabetic kidney disease in the population of type 1 diabetic patients in the era of intensive insulin treatment and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics